Align Technology Announced That The U.S. FDA Cleared Align's Invisalign Palatal Expander System For Commercial Availability In The U.S.
Portfolio Pulse from Benzinga Newsdesk
Align Technology has received clearance from the U.S. FDA for its Invisalign Palatal Expander System, making it commercially available in the U.S. This product provides a removable alternative to traditional palatal expanders and can be used in conjunction with Invisalign First aligners for comprehensive early intervention orthodontic treatment.
December 18, 2023 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Align Technology's Invisalign Palatal Expander System has been cleared by the FDA for use in the U.S., potentially increasing the company's product offerings and market share in the orthodontic space.
FDA approval of a new product typically leads to positive market reception, as it allows the company to expand its product line and potentially increase sales. The Invisalign Palatal Expander System could attract new customers looking for non-traditional orthodontic solutions, thus potentially boosting Align Technology's short-term stock performance.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100